Developing New Medicines Through Artificial Intelligence
On September 30, 2012, a computer program named “AlexNet” won an international competition and ushered in a new age of artificial intelligence (AI)....
BLOG
Read on
How Resilience Is Bringing Forward Thinking to Disrupt the Biomanufacturing Landscape to Increase Access to Medicines
While many biopharmaceutical companies are built to fulfil a need, Resilience was built to serve innovation. Founded during the COVID-19 pandemic in...
How Digital Twins are Shaping the Future of Continuous Bioprocessing with Resilience and Siemens
Resilience is thrilled to participate in a joint webinar, “How Digital Twins are Shaping the Future of Continuous Bioprocessing with Resilience and...
Cell Therapy – What Does It Take To Become a Mainstream Option
While cell therapies are still a small segment of therapeutics, the landscape is rapidly changing — with over 1,000 ongoing clinical trials and...
Resilience Becomes Biomanufacturing Resource Partner for California Institute for Regenerative Medicine
Resilience will aid in the development of CIRM grant applications as a biomanufacturing partner with awardees who are developing novel regenerative...
